Insight eNO System

The Insight eNO System measures exhaled nitric oxide (eNO), also known as FeNO, which is a well established indicator of airway inflammation in asthma. The Insight system is a highly accurate device, expressly designed for the physician’s office. It is non-invasive, safe, easy to use, and provides eNO results in less than a minute for better asthma management and care. Apieron's medical solution is a unique biosensor that, helps in asthma care by detecting trace amounts of nitric oxide molecules in a single human breath utilizing a proprietary technology.

Please note that the Insight eNO System is cleared by the FDA for use in the physician’s office only. Currently, there are no devices in the US approved for home-use to monitor exhaled nitric oxide. Please contact us if you have any questions.

Current methods and techniques used to diagnose, monitor and manage asthma do not measure airway inflammation, which is the primary pathogenic process leading to the signs and symptoms of asthma. The addition of eNO or FeNO, to the standard asthma management tools allows a window into the inflammatory process occurring in the airways that can help improve asthma control. Physician office measurement of eNO is a much awaited breakthrough in medical technology that provides physicians with a reliable tool to measure airway inflammation as an adjunct to the current diagnostic measures of asthma management, e.g. lung function. Exhaled nitric oxide has been established as a reliable marker of airway inflammation in asthma for over 10 years. Exhaled nitric has been the central focus of studies establishing its link to optimizing medication¹ and reflecting and predicting asthma control ^2,3,4.

Download Case Studies

Sales and Product Information
sales@apieron.com